Back to Search
Start Over
Third-line dovitinib in metastatic renal cell carcinoma.
- Source :
-
The Lancet. Oncology [Lancet Oncol] 2014 Mar; Vol. 15 (3), pp. 245-6. Date of Electronic Publication: 2014 Feb 17. - Publication Year :
- 2014
- Subjects :
- Female
Humans
Male
Niacinamide therapeutic use
Sorafenib
Antineoplastic Agents therapeutic use
Benzimidazoles therapeutic use
Carcinoma, Renal Cell drug therapy
Kidney Neoplasms drug therapy
Niacinamide analogs & derivatives
Phenylurea Compounds therapeutic use
Protein Kinase Inhibitors therapeutic use
Quinolones therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1474-5488
- Volume :
- 15
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The Lancet. Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 24556039
- Full Text :
- https://doi.org/10.1016/S1470-2045(14)70082-8